440 related articles for article (PubMed ID: 19073013)
41. Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks.
Stefanutti C; Lanti A; Di Giacomo S; Mareri M; De Lorenzo F; Landolfo A; Isacchi G
Transfus Apher Sci; 2004 Aug; 31(1):3-10. PubMed ID: 15294188
[TBL] [Abstract][Full Text] [Related]
42. The single center registry for therapeutic apheresis in Turkey: 11-year activity.
Kadikoylu G; Yavasoglu I; Ozkul A; Akyol A; Yukselen V; Guney E; Bolaman Z
Transfus Apher Sci; 2012 Aug; 47(1):61-5. PubMed ID: 22583545
[TBL] [Abstract][Full Text] [Related]
43. Recent advances in therapeutic apheresis.
Bosch T
J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117
[TBL] [Abstract][Full Text] [Related]
44. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
Strauss RG
J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
[TBL] [Abstract][Full Text] [Related]
45. Adverse events in therapeutic apheresis: a single center survey of various therapies.
Ishihara T; Inoue S; Takagi Y; Shimomura T; Sagami Y; Katayama S; Eguchi Y; Watase K; Miyamoto M; Minakata T
Ther Apher Dial; 2010 Dec; 14(6):589-95. PubMed ID: 21118368
[TBL] [Abstract][Full Text] [Related]
46. Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process.
Pierelli L; Perseghin P; Marchetti M; Messina C; Perotti C; Mazzoni A; Bacigalupo A; Locatelli F; Carlier P; Bosi A; ;
Transfusion; 2013 Oct; 53(10):2340-52. PubMed ID: 23305044
[TBL] [Abstract][Full Text] [Related]
47. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic apheresis: a review of complications and recommendations for prevention and management.
Mokrzycki MH; Balogun RA
J Clin Apher; 2011; 26(5):243-8. PubMed ID: 21898573
[TBL] [Abstract][Full Text] [Related]
49. The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails.
McLeod BC
J Crit Illn; 1991 May; 6(5):487-95. PubMed ID: 10147917
[TBL] [Abstract][Full Text] [Related]
50. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U
Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304
[TBL] [Abstract][Full Text] [Related]
51. The new WAA apheresis registry.
Stegmayr B; Klingstedt J; Grahn BE; Vinnervik P
Transfus Apher Sci; 2006 Jun; 34(3):259-62. PubMed ID: 16839818
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic apheresis in the Philippines.
Narciso CT
Transfus Apher Sci; 2005 Aug; 33(1):3-9. PubMed ID: 15964239
[TBL] [Abstract][Full Text] [Related]
53. Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease.
Hunt EA; Jain NG; Somers MJ
J Clin Apher; 2013 Feb; 28(1):36-47. PubMed ID: 23420594
[TBL] [Abstract][Full Text] [Related]
54. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections.
Yuan S; Gornbein J; Smeltzer B; Ziman AF; Lu Q; Goldfinger D
Transfusion; 2008 Jun; 48(6):1213-9. PubMed ID: 18346014
[TBL] [Abstract][Full Text] [Related]
56. Summary of results of 1991 ASFA apheresis survey. American Society for Apheresis.
Malchesky PS; Skibinski CI
J Clin Apher; 1993; 8(2):96-101. PubMed ID: 8226712
[TBL] [Abstract][Full Text] [Related]
57. [Apheresis in children: procedures and outcome].
Tummolo A; Colella V; Bellantuono R; Giordano M; Messina G; Puteo F; Sorino P; De Palo T
G Ital Nefrol; 2012; 29 Suppl 54():S125-9. PubMed ID: 22388843
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus.
Wong EC; Balogun RA
J Clin Apher; 2012; 27(3):132-7. PubMed ID: 22467438
[TBL] [Abstract][Full Text] [Related]
59. Training courses for pediatric apheresis on site; how apheresis technology transfer can be performed.
Witt V
Transfus Apher Sci; 2010 Oct; 43(2):223-5. PubMed ID: 20685167
[TBL] [Abstract][Full Text] [Related]
60. Complications of therapeutic apheresis in children.
Kara A; Turgut S; Cağlı A; Sahin F; Oran E; Tunç B
Transfus Apher Sci; 2013 Jun; 48(3):375-6. PubMed ID: 23685078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
